News

Here you will find our latest news and updates.

May 2019 updates to website

Uncategorized

The website has now been updated following May’s LMMG

The following drugs have been added/updated:

Ciclosporin 0.1% / 1 mg/mL eye drops (Verkazia®) — Severe vernal keratoconjunctivitis in children from 4 years of age and adolescents

Azelastine 137 microgram/Fluticasone propionate 50 microgram (120d) (Dymista ®) — Relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient

Certolizumab pegol NICE TA574 — For treating moderate to severe plaque psoriasis

Tildrakizumab NICE TA575 — For treating moderate to severe plaque psoriasis

The following guidelines have been added/updated:

Primary Care Good Prescribing Guide (Version 2.2) — Guidance updated

COPD Guideline (Version 1.8) — Guidance updated

E‑Cigarettes (version 2.0) — Position Statement updated